A study on CABI score in correlation with comorbidity,microbiological profile and early mortality among pulmonary TB patients with bacterial co-infection
Restricted accessResearch articleFirst published online January, 2026
A study on CABI score in correlation with comorbidity,microbiological profile and early mortality among pulmonary TB patients with bacterial co-infection
Tuberculosis (TB)-related deaths are preventable, yet research on co-infections primarily focuses on human immunodeficiency virus (HIV)-positive patients, leaving a gap for HIV-negative individuals. Early clinical monitoring is vital for reducing mortality, but research lacks clear links between mortality scoring, microbiological data, and prognostic factors. Despite early mortality being absent among our participants, we found prognostic markers such as comorbidity, smear-negative TB, high bacterial load, and bacterial co-infection correlated with elevated CABI scores.
KethireddySLightRBMirzanejadY, et al.Cooperative antimicrobial therapy of septic shock (CATSS) database group. Mycobacterium tuberculosis septic shock. Chest2013; 144: 474–482.
2.
SchutzCBarrDAndradeBB, et al.Clinical, microbiologic, and immunologic determinants of mortality in hospitalized patients with HIV-associated tuberculosis: a prospective cohort study. PLoS Med2019; 16: e1002840.
BhargavaABhargavaM. Tuberculosis deaths are predictable and preventable: comprehensive assessment and clinical care is the key. J Clin Tuberc Other Mycobact Dis2020; 19: 100155.
6.
KaratASOmarTvon GottbergA, et al.Autopsy prevalence of tuberculosis and other potentially treatable infections among adults with advanced HIV enrolled in out-patient care in South Africa. PLoS One2016; 11: e0166158.
7.
ShimazakiTTaniguchiTSaludarNRD, et al.Bacterial co-infection and early mortality among pulmonary tuberculosis patients in Manila, the Philippines. Int J Tuberc Lung Dis2018; 22: 65–72. PubMed.
8.
MayZSNeMAMyaML, et al.Bacterial co-infection in pulmonary tuberculosis. Myanmar Med J2019; 3: 9–14.
9.
Pefura-YoneEWBalkissouADPoka-MayapV, et al.Development and validation of a prognostic score during tuberculosis treatment. BMC Infect Dis2017; 17: 1–9.
10.
KuotuGCDialloADialloBD, et al.External validation and improvement of the CABI prognosis score in Guinean patients treated for tuberculosis in Conakry. Pan African Med J - One Health2022; 7: 6.
DoddPJYuenCMSismanidisC, et al.The global burden of tuberculosis mortality in children: a mathematical modelling study. Lancet Glob Health2017; 5: e898–e906. PubMed.
13.
GrahamSMMaraisBJAmanullahF. Tuberculosis in children and adolescents: progress and perseverance. Pathogens2022; 11: 392. PubMed.
14.
ShariefuddinWWSariSYPandjiTD. Comparison of life quality between diabetic and diabetic with tuberculosis patients. Althea Med J2016; 3: 440–445. PubMed.
WhitacreCCReingoldSCO'LooneyPA. A gender gap in autoimmunity. Science1999; 283: 1277–1278.
17.
MairCHawesSEAgneHD, et al.Factors associated with CD4 lymphocyte counts in HIV-negative Senegalese individuals. Clin Exp Immunol2008; 151: 432–440.
18.
BhattacharyaPTalukdarKBarmanB, et al.Clinical spectrum and medical comorbidities in tuberculosis: a hospital-based study in Northeast India. Cureus2020; 12: e10580.
19.
ShewadeHDGuptaVSatyanarayanaS, et al.History of household member with tuberculosis or related death in newly diagnosed patients in India. Public Health Action2020; 10: 53–56.
20.
MinJKimJSKimHW, et al.Effects of underweight and overweight on mortality in patients with pulmonary tuberculosis. Front Public Health2023; 11: 1236099.
21.
BhutiaTAdhikariL. Pulmonary mycoses among the clinically suspected cases of pulmonary tuberculosis. Int J Res Med Sci2015; 3: 260–268.
22.
BirlieATesfawGDejeneT, et al.Time to death and associated factors among tuberculosis patients in Dangila Woreda, Northwest Ethiopia. PLoS One2015; 10: e0144244.
23.
OliveiraSPSilveiraJTPDBeraldi-MagalhãesF, et al.Early death by tuberculosis as the underlying cause in a state of Southern Brazil: profile, comorbidities and associated vulnerabilities. Int J Infect Dis. 2019;80: S50–S57.
24.
FieldNLimMSMurrayJ, et al.Timing, rates, and causes of death in a large South African tuberculosis programme. BMC Infect Dis2014; 14: 3858.
25.
AdamuALGadanyaMAAbubakarIS, et al.High mortality among tuberculosis patients on treatment in Nigeria: a retrospective cohort study. BMC Infect Dis2017; 17: 170.
26.
ShewadeHDNagarajaSBVanithaB, et al.Screening for severe illness at diagnosis has the potential to prevent early TB deaths: programmatic experience from Karnataka, India. Glob Health Sci Pract2022; 10: e2100736.
27.
JonnalagadaSHarriesADZachariahR, et al.The timing of death in patients with tuberculosis who die during anti-tuberculosis treatment in Andhra Pradesh, South India. BMC Public Health2011; 11: 921.
28.
IliyasuGMohammadABYakasaiAM, et al.Gram-negative bacilli are a major cause of secondary pneumonia in patients with pulmonary tuberculosis: evidence from a cross-sectional study in a tertiary hospital in Nigeria. Trans R Soc Trop Med Hyg2018; 112: 252–254.
29.
AttiaEFPhoYNhemS, et al.Tuberculosis and other bacterial co-infection in Cambodia: a single center retrospective cross-sectional study. BMC Pulm Med2019; 19: 60.
